Phreesia Inc. (PHR) – Business Wire
-
Phreesia Announces Jack Callahan as New Chief Technology Officer
-
Phreesia Announces Fourth Quarter Fiscal 2024 Results
-
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
-
New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates
-
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
-
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
-
Phreesia’s Audrey Gato Named as a Top Woman Leader in SaaS
-
Phreesia’s Post-Script Engagement named one of PM360’s 2023 Most Innovative Technologies
-
Phreesia Announces Third Quarter Fiscal 2024 Results
-
CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024
-
Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance
-
Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results
-
Phreesia Announces Second Quarter Fiscal 2024 Results
-
Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Second Consecutive Year
-
Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms
-
Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience
-
Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results
-
Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers
-
Phreesia Names Lisa Egbuonu-Davis to its Board of Directors
-
Phreesia Announces First Quarter Fiscal 2024 Results
-
Phreesia Recognized as One of Modern Healthcare’s “Best Places to Work in Healthcare” for a Seventh Year
-
Phreesia’s Hilary Hatch Named a “Disrupter” in PM360’s ELITE 100
-
Phreesia Sets Release Date for Fiscal First Quarter 2024 Results
-
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
-
Phreesia Announces Fourth Quarter Fiscal 2023 Results
-
Phreesia Announces Chief Financial Officer Transition
-
Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
-
Phreesia’s Alexandra Beneville Named One of MM+M’s ‘Women to Watch’ for 2023
-
Phreesia’s Dan Nathan Named as a Top Software CTO of 2023
-
Phreesia Sets Release Date for Fiscal Fourth Quarter 2023 Results
-
Phreesia Included in 2023 Bloomberg Gender-Equality Index for the Third Consecutive Year
-
Phreesia and the Ad Council Partnership Drives Strong Engagement Across 3 Public Health Campaigns
-
Phreesia Life Sciences Named One of MM+M’s “Best Places to Work 2022”
-
Phreesia Announces Third Quarter Fiscal 2023 Results
-
Phreesia’s Sara DiNardo Selected as a Top Woman Leader in SaaS
-
Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results
-
Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy
-
Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup
-
Phreesia Announces Fiscal Second Quarter 2023 Results
-
Phreesia Sets Release Date for Fiscal Second Quarter 2023 Results
-
Phreesia Named to The Software Report’s “Top 100 Software Companies of 2022”
-
New Phreesia Research Reveals Patients’ Changing Preferences for their Digital Healthcare Experience
-
Compulink and Phreesia Partner to Help Practices Increase Efficiency and Profitability with an Integrated Intake Solution
-
Phreesia Announces Fiscal First Quarter 2023 Results
-
KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology
-
Phreesia Named One of Becker’s Healthcare’s “150 Top Places to Work in Healthcare”
-
Phreesia Selected as One of Modern Healthcare’s “Best Places to Work in Healthcare” for a Sixth Year
-
Phreesia’s Danielle Lynch Named a ‘Sales MVP’ in PM360’s ELITE 100
-
Phreesia Sets Release Date for Fiscal First Quarter 2023 Results
-
Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022
Back to PHR Stock Lookup
